Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Eur J Cancer. 2012 Oct 22;49(4):875–883. doi: 10.1016/j.ejca.2012.10.002

Table 1.

Clinicopathologic and treatment characteristics of patients undergoing interdigitated neoadjuvant chemoradiotherapy (N=66)

n (%)
Gender
Male 50 (76)

Age at diagnosis (years)
Mean 51
Median 53
Range 18–73

Primary vs. recurrent at presentation
Primary 63 (95)
Recurrent 3 (5)

Histology
Undifferentiated high grade pleomorphic sarcoma 23 (35)
Liposarcoma 20 (30)
Synovial sarcoma 12 (18)
Myxofibrosaroma 6 (9)
Malignant peripheral nerve sheath tumor 3 (4)
Myofibroblastic sarcoma 1 (2)
Angiosarcoma 1 (2)

Location
Thigh 36 (55)
Lower leg 8 (12)
Axilla/Shoulder 7 (11)
Buttock 5 (8)
Arm 4 (6)
Popliteal space 2 (3)
Foot 1 (2)
Back 1 (2)
Elbow 1 (2)
Scapula 1 (2)

Pathologic dimension (cm)
Mean 12
Median 10
Range 2.5–35.5

Histologic grade
1 0 (0)
2 33 (50)
3 33 (50)

Surgical margin*
Negative (≥ 1mm) 38 (58)
Close (< 1mm) 19 (29)
Positive 7 (11)

Percent necrosis*
0–25 % 10 (15)
26–50 % 5 (8)
51–75 % 12 (18)
76–100 % 35 (53)
Unknown 4 (6)

Extent of resection*
Radical resection 62 (94)
Wide local excision 1 (2)
Amputation 1 (2)

Surgical reconstruction 18 (27) **
Pedicled flap +/− STSG 8 (12)
Free flap + STSG 2 (3)
Complex primary closure 4 (6)
Prophylactic long bone fixation 5 (8)

STSG: Split thickness skin graft, NA: Neoadjuvant, IORT Intraoperative radiation therapy,

*

2 patients did not receive surgery,

**

1 patient underwent prophylactic fixation + sartorius muscle flap.